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Background. Light chain amyloidosis (AL) is caused by the overproduction, misfolding and 
aggregation of immunoglobulin light chains (LCs) that tend to deposit as amyloid fibrils in 
the cardiac tissue1. Nowadays, the molecular details underling LCs soluble cardiotoxicity 
and fibril formation remain to be fully elucidated. It has been suggested a relationship 
between conformational flexibility and amyloidogenicity, indicating protein thermal stability 
and dynamics as factors able to influence the complex processes of misfolding and 
aggregation2,3. To date, no compelling correlations have been identified between LCs 
cardiotoxicity and primary sequence. Here we present a pivotal mutagenesis study in which 
we produce and characterise a mutated variant of the toxic H6 LC (mH6). Our purpose is to 
abrogate the toxicity typical of H6 yielding to a non-cardiotoxic LC and to understand the 
biophysical and biochemical changes underlying such loss of toxicity.  
 
Material and Methods. H6 mutant design was carried out combining the results of 
bioinformatics tools for protein stability predictions and sequence multi-alignment. H6 
sequence was mutated into mH6 using side directed mutagenesis. E. coli was used to 
express LCs, which are then refolded and purified by chromatographic methods as 
previously reported3. For protein characterization both spectroscopic (Circular Dichroism, 
Fluorescence) and structural (X-ray crystallography) techniques were applied. In-vivo 
toxicity assessment was carried out measuring C. elegans’ pharynx pumping rate4.  
 
Results. The design of mutated H6 was performed applying an innovative method that 
correlates structural data with toxicity (Figure 1). A set of thermal stabilizing mutation 
candidates were found through an hybrid approach involving: i) multi-sequence analysis and 
ii) energetic calculations. H6 amino acid sequence was aligned against a multiple myeloma 
sequence database, in order to identify the conserved amino acids spots associated with non-
toxic LC (Figure 1A). The crystal structure of H6 was analysed by bioinformatics tools that 
calculated the most favourable mutations to achieve protein stabilisation (Figure 1B). Final 
mutations selection was obtained by merging and ranking the best outcomes of the two 
methods (Figure 1C), which led to the identification of three point mutations located in the 
variable domain. 
Preliminary data on mH6 in vivo toxicity seem to indicate a significant decrease in the 
mutant toxic profile compared to the wild type cardiotoxic H6. This points out the critical 
role of specific amino acid positions in determining the toxic behaviour.               
Interestingly, the melting temperatures of H6 and mH6 monitored by Far-UV circular    
dichroism are comparable (Tm H6= 43.9 – 54.5 °C, Tm mH6=53.8 °C). However unfolding 
profiles are not perfectly superposable suggesting different unfolding transitions: mH6 
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appear to have a more defined transition, which possibly reflect a more compact domain 
organization than H6 three step unfolding3. Limited proteolysis data revealed slower 
proteolytic kinetics for the mutant, hence reduced fold stability. 
The crystal structure of mH6 has been determined at 2.1 Å resolution, displaying a 
homodimeric organization common to all LC dimers. Secondary structure superposition 
does not show evident differences between the H6 structure and the mH6 one, giving an 
r.m.s.d. value of 0.3 Å for the overall dimers superposition, indicating that the mutagenesis 
has no impact on the native protein organization and dimerization.  
 
Figure 1. (A) Representative sequence multi-alignment of myeloma LCs against H6.  
Sequence conservation and consensus sequence are depicted by histograms. (B) 
Bioinformatics analysis using H6 structure as input run to identify possible mutation spots. 
(C) The combination of outputs from (A) and (B) lead the mutation spot selection and 
subsequent protein production and characterization. 
 
Discussion and conclusions. Previous biophysical findings indicate that low fold stability 
and high protein dynamics correlate with LC amyloidogenicity3. Our data showed that the 
toxicity of a soluble LC could be tuned by introducing specific point mutations. This 
evidence points out the importance of the primary sequence for cardiotoxic LCs. Moreover, 
our data strengthen the hypothesis that links LCs toxic behaviour in vivo to thermal stability 
and dynamics. 
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